Multimodal Prognostic System for Heart Failure: A Multi-Center Study
NCT ID: NCT06558448
Last Updated: 2024-08-16
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
100000 participants
OBSERVATIONAL
2024-08-31
2024-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
This study aims to address the following main questions:
1. What are the clinical characteristics and current treatment status of heart failure patients?
2. What factors influence the onset of heart failure and the prognosis of patients?
3. How can real-world big data be utilized to construct an accurate heart failure prognosis assessment model?
4. How can this prognosis assessment model help improve the therapeutic effects and quality of life for heart failure patients?
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Study of the Prognosis of Patients With Heart Failure With Preserved Ejection Fraction
NCT05496439
Heart Failure Evaluation Study
NCT05583513
Study of China Heart Failure Registry to Investigate Characteristics of Patients in China
NCT02664818
Risk Evaluation and Management in Heart Failure
NCT02998788
Prognosis Predictors for Heart Failure
NCT04838470
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Diagnostic Criteria: Patients should have a discharge diagnosis of heart failure according to the guidelines for heart failure diagnosis and treatment.
Time Frame: The discharge time of patients should be between January 2011 and December 2024 to collect and analyze data from the past several years.
Data Integrity: There is a preference for including medical records with high data integrity, but the specific criteria may be adjusted according to the actual situation of the dataset.
Exclusion Criteria
Diagnostic Inconsistency: Patients with unclear diagnoses or potential for confusion with other diseases may be excluded to ensure the specificity of the study.
Non-standard Treatment: Patients who have not received treatment according to the established treatment protocol may be excluded to reduce the impact of treatment variability on the study results.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Chongqing Medical University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
QianQian Wang
student
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CYS240347
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.